Riik: Iisrael
keel: inglise
Allikas: Ministry of Health
LEVETIRACETAM
DEXCEL PHARMA TECHNOLOGIES LTD
N03AX14
TABLETS
LEVETIRACETAM 1000 MG
PER OS
Required
DEXCEL LTD, ISRAEL
LEVETIRACETAM
LEVETIRACETAM
Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
2018-03-31